tiprankstipranks
Arcutis Biotherapeutics appoints Todd Tucker as CHRO
PremiumThe FlyArcutis Biotherapeutics appoints Todd Tucker as CHRO
1M ago
Arcutis presents late-breaking data from INTEGUMENT-PED Phase 3 trial
PremiumThe Fly
Arcutis presents late-breaking data from INTEGUMENT-PED Phase 3 trial
1M ago
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
PremiumPress Releases
Arcutis Presents Late-Breaking Data From INTEGUMENT-PED Phase 3 Trial of Roflumilast Cream 0.05% in Atopic Dermatitis in Children Ages 2 to 5 at the American Academy of Dermatology Annual Meeting
1M ago
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress ReleasesArcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2M ago
Arcutis Biotherapeutics reports Q4 EPS (72c), consensus (77c)
PremiumThe Fly
Arcutis Biotherapeutics reports Q4 EPS (72c), consensus (77c)
2M ago
Arcutis Biotherapeutics price target raised to $16 from $8 at Mizuho
PremiumThe Fly
Arcutis Biotherapeutics price target raised to $16 from $8 at Mizuho
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100